This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Financial Companies: Ethos Technologies Inc. Class A (LIFE) and Allstate (ALL)

Tipranks - Mon Jun 22, 11:30AM CDT

Analysts have been eager to weigh in on the Financial sector with new ratings on Ethos Technologies Inc. Class A (LIFE) and Allstate (ALL).

TipRanks' Prime Week Sale - 70% Off

Ethos Technologies Inc. Class A (LIFE)

Bank of America Securities analyst Mike McGovern maintained a Buy rating on Ethos Technologies Inc. Class A on June 18 and set a price target of $28.00. The company’s shares closed last Thursday at $16.07.

According to TipRanks.com, McGovern is a 1-star analyst with an average return of -2.7% and a 39.0% success rate. McGovern covers the NA sector, focusing on stocks such as ACV Auctions, Carvana Co, and Wayfair. ;'>

Ethos Technologies Inc. Class A has an analyst consensus of Strong Buy, with a price target consensus of $26.58, implying a 67.2% upside from current levels. In a report issued on June 4, William Blair also maintained a Buy rating on the stock.

See Insiders’ Hot Stocks on TipRanks >>

Allstate (ALL)

In a report issued on June 18, Bob Huang from Morgan Stanley maintained a Hold rating on Allstate, with a price target of $215.00. The company’s shares closed last Thursday at $221.17.

According to TipRanks.com, Huang is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -3.1% and a 51.6% success rate. Huang covers the Financial sector, focusing on stocks such as Neptune Insurance Holdings, Inc. Class A, Hamilton Insurance Group, Ltd. Class B, and Bowhead Specialty Holdings Inc. ;'>

Currently, the analyst consensus on Allstate is a Moderate Buy with an average price target of $235.17, implying a 6.1% upside from current levels. In a report issued on June 7, KBW also downgraded the stock to Hold with a $242.00 price target.

Read More on LIFE:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.